BIOVENTUS INC - A (BVS) Stock Fundamental Analysis
NASDAQ:BVS • US09075A1088
8.13 USD
+0.05 (+0.62%)
Last: Feb 12, 2026, 03:29 PM
We assign a fundamental rating of 5 out of 10 to BVS. BVS was compared to 186 industry peers in the Health Care Equipment & Supplies industry. There are concerns on the financial health of BVS while its profitability can be described as average. BVS scores decently on growth, while it is valued quite cheap. This could make an interesting combination.
1. Profitability
1.1 Basic Checks
- BVS had positive earnings in the past year.
- BVS had a positive operating cash flow in the past year.
- The reported net income has been mixed in the past 5 years: BVS reported negative net income in multiple years.
- Of the past 5 years BVS 4 years had a positive operating cash flow.
1.2 Ratios
- BVS has a Return On Assets of 1.11%. This is in the better half of the industry: BVS outperforms 75.27% of its industry peers.
- The Return On Equity of BVS (4.71%) is better than 76.88% of its industry peers.
- The Return On Invested Capital of BVS (6.62%) is better than 80.65% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.11% | ||
| ROE | 4.71% | ||
| ROIC | 6.62% |
ROA(3y)-11.81%
ROA(5y)-6.59%
ROE(3y)-54.27%
ROE(5y)-31.1%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- BVS's Profit Margin of 1.39% is fine compared to the rest of the industry. BVS outperforms 74.19% of its industry peers.
- The Operating Margin of BVS (8.03%) is better than 75.81% of its industry peers.
- In the last couple of years the Operating Margin of BVS has declined.
- BVS has a Gross Margin of 67.76%. This is in the better half of the industry: BVS outperforms 73.66% of its industry peers.
- In the last couple of years the Gross Margin of BVS has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.03% | ||
| PM (TTM) | 1.39% | ||
| GM | 67.76% |
OM growth 3Y-2.88%
OM growth 5Y-14.52%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.21%
GM growth 5Y-1.56%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BVS is destroying value.
- BVS has more shares outstanding than it did 1 year ago.
- The number of shares outstanding for BVS has been increased compared to 5 years ago.
- BVS has a better debt/assets ratio than last year.
2.2 Solvency
- Based on the Altman-Z score of 1.27, we must say that BVS is in the distress zone and has some risk of bankruptcy.
- BVS has a Altman-Z score (1.27) which is comparable to the rest of the industry.
- BVS has a debt to FCF ratio of 6.22. This is a slightly negative value and a sign of low solvency as BVS would need 6.22 years to pay back of all of its debts.
- With a decent Debt to FCF ratio value of 6.22, BVS is doing good in the industry, outperforming 76.88% of the companies in the same industry.
- A Debt/Equity ratio of 1.93 is on the high side and indicates that BVS has dependencies on debt financing.
- The Debt to Equity ratio of BVS (1.93) is worse than 81.18% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.93 | ||
| Debt/FCF | 6.22 | ||
| Altman-Z | 1.27 |
ROIC/WACC0.61
WACC10.81%
2.3 Liquidity
- A Current Ratio of 1.74 indicates that BVS should not have too much problems paying its short term obligations.
- BVS has a worse Current ratio (1.74) than 67.20% of its industry peers.
- A Quick Ratio of 1.14 indicates that BVS should not have too much problems paying its short term obligations.
- BVS has a worse Quick ratio (1.14) than 70.97% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.74 | ||
| Quick Ratio | 1.14 |
3. Growth
3.1 Past
- BVS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 51.28%, which is quite impressive.
- The earnings per share for BVS have been decreasing by -16.93% on average. This is quite bad
- BVS shows a small growth in Revenue. In the last year, the Revenue has grown by 1.58%.
- BVS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.01% yearly.
EPS 1Y (TTM)51.28%
EPS 3Y-16.93%
EPS 5YN/A
EPS Q2Q%150%
Revenue 1Y (TTM)1.58%
Revenue growth 3Y9.98%
Revenue growth 5Y11.01%
Sales Q2Q%-0.23%
3.2 Future
- Based on estimates for the next years, BVS will show a very strong growth in Earnings Per Share. The EPS will grow by 25.05% on average per year.
- BVS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.58% yearly.
EPS Next Y41.83%
EPS Next 2Y30.71%
EPS Next 3Y25.05%
EPS Next 5YN/A
Revenue Next Year0.33%
Revenue Next 2Y3.66%
Revenue Next 3Y4.58%
Revenue Next 5YN/A
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 13.78, the valuation of BVS can be described as correct.
- 90.86% of the companies in the same industry are more expensive than BVS, based on the Price/Earnings ratio.
- Compared to an average S&P500 Price/Earnings ratio of 28.18, BVS is valued rather cheaply.
- The Price/Forward Earnings ratio is 10.13, which indicates a very decent valuation of BVS.
- 95.16% of the companies in the same industry are more expensive than BVS, based on the Price/Forward Earnings ratio.
- BVS's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.01.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.78 | ||
| Fwd PE | 10.13 |
4.2 Price Multiples
- BVS's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. BVS is cheaper than 89.78% of the companies in the same industry.
- Based on the Price/Free Cash Flow ratio, BVS is valued cheaply inside the industry as 96.24% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.58 | ||
| EV/EBITDA | 10.31 |
4.3 Compensation for Growth
- BVS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- BVS's earnings are expected to grow with 25.05% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.33
PEG (5Y)N/A
EPS Next 2Y30.71%
EPS Next 3Y25.05%
5. Dividend
5.1 Amount
- No dividends for BVS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NASDAQ:BVS (2/12/2026, 3:29:42 PM)
8.13
+0.05 (+0.62%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-04 2025-11-04/bmo
Earnings (Next)03-09 2026-03-09/amc
Inst Owners74.45%
Inst Owner Change-1.18%
Ins Owners2.5%
Ins Owner Change0.31%
Market Cap672.84M
Revenue(TTM)563.83M
Net Income(TTM)7.82M
Analysts80
Price Target15.3 (88.19%)
Short Float %2.87%
Short Ratio6.4
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)14.08%
Min EPS beat(2)-0.99%
Max EPS beat(2)29.14%
EPS beat(4)3
Avg EPS beat(4)86.47%
Min EPS beat(4)-0.99%
Max EPS beat(4)239.51%
EPS beat(8)7
Avg EPS beat(8)133.13%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.3%
Min Revenue beat(2)-0.67%
Max Revenue beat(2)0.07%
Revenue beat(4)2
Avg Revenue beat(4)1.04%
Min Revenue beat(4)-0.67%
Max Revenue beat(4)4.79%
Revenue beat(8)6
Avg Revenue beat(8)4.08%
Revenue beat(12)9
Avg Revenue beat(12)2.76%
Revenue beat(16)10
Avg Revenue beat(16)1.33%
PT rev (1m)0%
PT rev (3m)2.27%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)3.13%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.01%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.78 | ||
| Fwd PE | 10.13 | ||
| P/S | 1.19 | ||
| P/FCF | 12.58 | ||
| P/OCF | 12.01 | ||
| P/B | 4.05 | ||
| P/tB | N/A | ||
| EV/EBITDA | 10.31 |
EPS(TTM)0.59
EY7.26%
EPS(NY)0.8
Fwd EY9.88%
FCF(TTM)0.65
FCFY7.95%
OCF(TTM)0.68
OCFY8.33%
SpS6.81
BVpS2.01
TBVpS-2.64
PEG (NY)0.33
PEG (5Y)N/A
Graham Number5.16
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.11% | ||
| ROE | 4.71% | ||
| ROCE | 8.38% | ||
| ROIC | 6.62% | ||
| ROICexc | 7.18% | ||
| ROICexgc | 31.69% | ||
| OM | 8.03% | ||
| PM (TTM) | 1.39% | ||
| GM | 67.76% | ||
| FCFM | 9.48% |
ROA(3y)-11.81%
ROA(5y)-6.59%
ROE(3y)-54.27%
ROE(5y)-31.1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y44.62%
ROICexgc growth 5Y-8.7%
ROICexc growth 3Y36.86%
ROICexc growth 5Y-12.41%
OM growth 3Y-2.88%
OM growth 5Y-14.52%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.21%
GM growth 5Y-1.56%
F-Score8
Asset Turnover0.8
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.93 | ||
| Debt/FCF | 6.22 | ||
| Debt/EBITDA | 3.44 | ||
| Cap/Depr | 5.36% | ||
| Cap/Sales | 0.45% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 60.26% | ||
| Profit Quality | 683.69% | ||
| Current Ratio | 1.74 | ||
| Quick Ratio | 1.14 | ||
| Altman-Z | 1.27 |
F-Score8
WACC10.81%
ROIC/WACC0.61
Cap/Depr(3y)9.96%
Cap/Depr(5y)13.06%
Cap/Sales(3y)1.19%
Cap/Sales(5y)1.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)51.28%
EPS 3Y-16.93%
EPS 5YN/A
EPS Q2Q%150%
EPS Next Y41.83%
EPS Next 2Y30.71%
EPS Next 3Y25.05%
EPS Next 5YN/A
Revenue 1Y (TTM)1.58%
Revenue growth 3Y9.98%
Revenue growth 5Y11.01%
Sales Q2Q%-0.23%
Revenue Next Year0.33%
Revenue Next 2Y3.66%
Revenue Next 3Y4.58%
Revenue Next 5YN/A
EBIT growth 1Y178.93%
EBIT growth 3Y6.82%
EBIT growth 5Y-5.11%
EBIT Next Year16.21%
EBIT Next 3Y12.72%
EBIT Next 5YN/A
FCF growth 1Y29806.1%
FCF growth 3Y34.24%
FCF growth 5Y-0.3%
OCF growth 1Y448.75%
OCF growth 3Y19.05%
OCF growth 5Y-0.96%
BIOVENTUS INC - A / BVS FAQ
Can you provide the ChartMill fundamental rating for BIOVENTUS INC - A?
ChartMill assigns a fundamental rating of 5 / 10 to BVS.
What is the valuation status for BVS stock?
ChartMill assigns a valuation rating of 8 / 10 to BIOVENTUS INC - A (BVS). This can be considered as Undervalued.
Can you provide the profitability details for BIOVENTUS INC - A?
BIOVENTUS INC - A (BVS) has a profitability rating of 5 / 10.
What is the valuation of BIOVENTUS INC - A based on its PE and PB ratios?
The Price/Earnings (PE) ratio for BIOVENTUS INC - A (BVS) is 13.78 and the Price/Book (PB) ratio is 4.05.
What is the financial health of BIOVENTUS INC - A (BVS) stock?
The financial health rating of BIOVENTUS INC - A (BVS) is 3 / 10.